European Society of Toxicology In Vitro

Toxicology in Vitro is now accepting manuscripts for the Special Issue arising from the ESTIV 2026 Congress held in Maastricht. The collection takes its direction from the congress theme — “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs” — and is open until 31 December 2026.

The ERA4NAMs Working Group on Education and Training is conducting a mapping exercise to identify existing training activities, educational resources, and capacity-building initiatives related to New Approach Methodologies (NAMs) across Europe and beyond.

The European Society of Toxicology In Vitro (ESTIV) is proud to announce the recipients of the inaugural Liebsch & Spielmann Award for Contributions to the Validation of Alternative Methods.

The European Society of Toxicology In Vitro (ESTIV) joins the international scientific community in mourning the loss of Dr. Alan M. Goldberg, who passed away on 9 June 2026 at the age of 86.

As we prepare for the 23rd ESTIV Congress in Maastricht in 2026, we found ourselves looking back at the remarkable history of our community.
Many people know that the European Society of Toxicology In Vitro (ESTIV) was formally established in 1994. What is less widely known is that the roots of ESTIV go much deeper.

This interactive session, brings together early-career researcher communities from three major European initiatives in toxicology and chemical safety: the ASPIS Academy, the PARC Junior Community, and the VICT3R Early Stage Researcher Network.

The Toxicology in Vitro Special Issue linked to ESTIV 2026 brings together selected papers from the congress, highlighting cutting-edge research presented in Maastricht from 29 June to 2 July 2026. Aligned with the theme “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs.

Be aware that there are fraudulent e-mails sent out by scammers offering the congress attendance lists, accommodation, services etc